Frequently Asked Questions
Home / FAQs
For Canadian healthcare professionals only.
Please note: Local policy and the Product Monograph supersede this FAQ. Follow your hospital’s transfusion and emergency haemostasis guidelines.
Education, consent, and handover
Explain that Fibryga is a human plasma-derived fibrinogen concentrate used to restore a key clotting protein rapidly to control bleeding. Describe benefits and risks, including rare allergic reactions and very low residual infection risk. Document consent or emergency exception.
Indication, amount given, lab values before and after, re-check plan, and signs to watch for. State the overall bleeding control status and the next laboratory target time.
Octapharma Canada provides a patient support program called Procare, for more information regarding his program, email medinfo.canada@octapharma.com
Access to Procare is evaluated based on priority and patient requirements.